The invention discloses
lactobacillus buchneri and application thereof, and relates to the technical field of microorganisms. The strain is preserved in the China General
Microbiological Culture Collection Center on November 28, 2024, and the preservation number is CGMCC (China General
Microbiological Culture Collection Center) NO.32833. The strain has efficient
nucleoside degradation capacity, can completely degrade
nucleoside within 30 minutes, shows excellent
acid resistance and cholate tolerance, is high in
survival rate in an in-vitro simulated
digestion environment, is sensitive to
antibiotics, does not have hemolytic activity, has remarkable
uric acid reduction capacity, can relieve
hyperuricemia, and has the effects of improving blood
lipid metabolism, reducing blood fat and reducing blood fat. The strain has outstanding performance in the aspects of repairing
kidney injury caused by
hyperuricemia, relieving
fatty liver and inhibiting
inflammation, can promote generation of short-chain
fatty acid and regulate the intestinal
flora structure, can be used for prevention and
adjuvant therapy of
hyperuricemia and metabolic diseases thereof, and has wide market application prospects in the
nutrition and health industry.